Basal cell carcinoma: Treatment with imiquimod

International Journal of Dermatology

Volumn 46, Issue 5, 2007, Pages 539-542

  Pérez, M P Bukhardt ^a   Ruiz Villaverde, Ricardo ^b,e   Díaz, M J Naranjo ^c   Melguizo J Blasco, J B ^d   Sintes, R Naranjo ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Dermatology Unit   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d Hospital del Ejido   (Spain)

^e NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; NEOMYCIN;

ADULT; AGED; AMBULATORY CARE; ARTHRALGIA; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CONTROLLED STUDY; DERMATOLOGY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; EXPERIENCE; FEMALE; HEALTH CARE COST; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PAIN; PARESTHESIA; PRURITUS; SCAR FORMATION; SKIN BLEEDING; SKIN CARCINOMA; SKIN DEFECT; SPAIN; THERAPY EFFECT;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; BIOPSY; CARCINOMA, BASAL CELL; ERYTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 34248193388     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03230.x     Document Type: Article

References (12)

1. Buendia Eisman A, Muñoz Negro JE, Serrano Ortega S. Epidemiología del cáncer cutáneo no melanoma. Piel 2002; 17: 3-6.
2. Beutner KR, Geisse JR, Helan D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-1007.
3. Chen TM, Rosen T, Orengo I. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: A case report and review of the literature. Dermatol Surg 2002; 28: 344-346.
4. Drehs MM, Cook-Bolden F, Tanzi EL, et al. Successful treatment of multiple basal cell carcinoma with topical imiquimod: A case report and review of the literature. Dermatol Surg 2002; 28: 427-429.
5. Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol 1998; 38: 230-239.
6. Marks R, Gebauer K, Schumack S, et al., and the Australasian Multicentre Trial Group. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicentre 6-week dose multiple response trial. J Am Acad Dermatol 2001; 44: 807-813.
7. Schulze HJ, Cribier B, Requena L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-947.
8. Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III randomized vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-733.
9. Jiang SB. Pathology: Basal Cell Carcinoma. URL http://www.emedicine.com [accessed August 2005].
10. Blasco J, Ruiz Villaverde R, Naranjo R, et al. Queratoacantoma solitario. Respuesta al imiquimod al 5% en crema. Dermatol Cosmet 2001; 11: 149-152.
11. Rodríguez Caravaca G, Herrera Sanchez M, Villar Del Campo I, et al. Validez del diagnóstico clínico del carcinoma basocelular. Piel 1998; 6: 273.
12. Schoeder TL, Sengleman RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002; 46: 545-548.